Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Adarotene (ST1926) 是一种细胞凋亡诱导剂,通过产生 DNA 损伤,来阻止人类肿瘤细胞的增殖。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 233 | 现货 | ||
2 mg | ¥ 332 | 现货 | ||
5 mg | ¥ 539 | 现货 | ||
10 mg | ¥ 983 | 现货 | ||
25 mg | ¥ 1,850 | 现货 | ||
50 mg | ¥ 2,950 | 现货 | ||
100 mg | ¥ 4,350 | 现货 | ||
500 mg | ¥ 9,130 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 593 | 现货 |
产品描述 | Adarotene (ST1926) is an effective apoptosis inducer. It surprisingly produces DNA damage and exhibits a potent antiproliferative activity on a large panel of human tumor cells. |
体外活性 | Adarotene causes cell accumulation in the G1/S or S phase of the cell cycle depending on tumor cells IGROV-1 and DU145. Adarotene causes dose-dependent growth inhibition in a large panel of human tumor cell lines with IC50 ranging from 0.1 to 0.3 μM [1]. Adarotene is apoptotic and cytotoxic on a large spectrum of cancerous and leukemic cells, including freshly isolated AML blasts in primary culture. Adarotene treatment of cells results in rapid accumulation of intracellular calcium [2]. |
体内活性 | Adarotene (30, 40 mg/kg, p.o.) causes a significant and dose-dependent increase in the life span of NB4-bearing SCID mice without overt toxicity [2]. Adarotene (15, 20 mg/kg, p.o.) leads to a significant tumor growth inhibition in a human ovarian carcinoma, A2780/DX, and in human melanoma, MeWo, growing in nude mice [1]. |
别名 | ST1926 |
分子量 | 374.47 |
分子式 | C25H26O3 |
CAS No. | 496868-77-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (120.17 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6704 mL | 13.3522 mL | 26.7044 mL | 66.761 mL |
5 mM | 0.5341 mL | 2.6704 mL | 5.3409 mL | 13.3522 mL | |
10 mM | 0.267 mL | 1.3352 mL | 2.6704 mL | 6.6761 mL | |
20 mM | 0.1335 mL | 0.6676 mL | 1.3352 mL | 3.3381 mL | |
50 mM | 0.0534 mL | 0.267 mL | 0.5341 mL | 1.3352 mL | |
100 mM | 0.0267 mL | 0.1335 mL | 0.267 mL | 0.6676 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Adarotene 496868-77-0 Apoptosis Inhibitor ST1926 inhibit ST 1926 ST-1926 inhibitor